tiprankstipranks
Advertisement
Advertisement

DE:6IRA Stock Latest News

IRLAB to Showcase Expanding Parkinson’s Pipeline at Redeye Healthcare Day 2026
Company AnnouncementsIRLAB to Showcase Expanding Parkinson’s Pipeline at Redeye Healthcare Day 2026
4d ago
IRLAB Showcases Parkinson’s Pipeline and AI Discovery Advances at AD/PD 2026
PremiumCompany Announcements
IRLAB Showcases Parkinson’s Pipeline and AI Discovery Advances at AD/PD 2026
27d ago
IRLAB to Showcase Parkinson’s Pipeline at Gothenburg Life Science Day
PremiumCompany Announcements
IRLAB to Showcase Parkinson’s Pipeline at Gothenburg Life Science Day
1M ago
IRLAB Triggers USD 3 Million Milestone as First Patient Dosed in IRL757 Parkinson’s Apathy Trial
PremiumCompany Announcements
IRLAB Triggers USD 3 Million Milestone as First Patient Dosed in IRL757 Parkinson’s Apathy Trial
2M ago
IRLAB Advances CNS Pipeline as 2025 Loss Widens and Cash Position Strengthens
PremiumCompany Announcements
IRLAB Advances CNS Pipeline as 2025 Loss Widens and Cash Position Strengthens
2M ago
IRLAB Wins Expert Backing to Advance Parkinson’s Drug Pirepemat After Positive Phase IIb Signals
PremiumCompany AnnouncementsIRLAB Wins Expert Backing to Advance Parkinson’s Drug Pirepemat After Positive Phase IIb Signals
2M ago
IRLAB to Webcast Year-End 2025 Results as Parkinson’s Pipeline Advances
Premium
Company Announcements
IRLAB to Webcast Year-End 2025 Results as Parkinson’s Pipeline Advances
2M ago
IRLAB partners with Denmark’s Biomia to apply AI-driven ISP platform to CNS drug candidates
Premium
Company Announcements
IRLAB partners with Denmark’s Biomia to apply AI-driven ISP platform to CNS drug candidates
3M ago
IRLAB Wins Green Light for Phase Ib Trial of Novel Apathy Drug in Parkinson’s
PremiumCompany Announcements
IRLAB Wins Green Light for Phase Ib Trial of Novel Apathy Drug in Parkinson’s
4M ago
IRLAB Secures New Patent for Mesdopetam, Strengthening Market Position
PremiumCompany Announcements
IRLAB Secures New Patent for Mesdopetam, Strengthening Market Position
4M ago
IRLAB to Present at Redeye Technology & Life Science Day 2025
PremiumCompany Announcements
IRLAB to Present at Redeye Technology & Life Science Day 2025
5M ago
IRLAB Therapeutics Appoints Nomination Committee for 2026 AGM
PremiumCompany Announcements
IRLAB Therapeutics Appoints Nomination Committee for 2026 AGM
5M ago
IRLAB’s Research Advances Highlighted at AD/PD 2026 Conference
PremiumCompany AnnouncementsIRLAB’s Research Advances Highlighted at AD/PD 2026 Conference
5M ago
IRLAB Therapeutics Advances Drug Development with New Funding and Patent
Premium
Company Announcements
IRLAB Therapeutics Advances Drug Development with New Funding and Patent
6M ago
IRLAB Therapeutics to Present Q3 2025 Interim Report via Webcast
Premium
Company Announcements
IRLAB Therapeutics to Present Q3 2025 Interim Report via Webcast
6M ago
IRLAB Therapeutics Appoints New CFO to Strengthen Leadership
PremiumCompany Announcements
IRLAB Therapeutics Appoints New CFO to Strengthen Leadership
6M ago
IRLAB to Present at Redeye Neurology Event, Expanding Investor Engagement
PremiumCompany Announcements
IRLAB to Present at Redeye Neurology Event, Expanding Investor Engagement
6M ago
IRLAB Advances IRL757 for Apathy in Parkinson’s Disease with MSRD Partnership
PremiumCompany Announcements
IRLAB Advances IRL757 for Apathy in Parkinson’s Disease with MSRD Partnership
6M ago
IRLAB Secures Extended Patent Protection for Mesdopetam in China
PremiumCompany Announcements
IRLAB Secures Extended Patent Protection for Mesdopetam in China
7M ago
IRLAB Therapeutics Increases Shares and Votes Following Rights Issue
PremiumCompany AnnouncementsIRLAB Therapeutics Increases Shares and Votes Following Rights Issue
8M ago
IRLAB Therapeutics Strengthens Patent Portfolio and Financial Position Amid Development Progress
Premium
Company Announcements
IRLAB Therapeutics Strengthens Patent Portfolio and Financial Position Amid Development Progress
8M ago
IRLAB Therapeutics to Present Q2 2025 Interim Report
Premium
Company Announcements
IRLAB Therapeutics to Present Q2 2025 Interim Report
8M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >